Karen E. Sexton

Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor

Andrea J. Gonzales, Kenneth E. Hook, Irene W. Althaus et al. · Molecular Cancer Therapeutics · 2008 · 221 citations · Full text

Medicine, Oncology, Pharmacology +15

A Highly Efficient Procedure for 3-Sulfenylation of Indole-2-carboxylates

Kevin M. Schlosser, Alexei P. Krasutsky, Harriet W. Hamilton et al. · Organic Letters · 2004 · 166 citations

Natural Sciences, Chemistry, Green Chemistry +9

Adulteration of Urine by “Urine Luck”

Alan H.B. Wu, Ben Bristol, Karen E. Sexton et al. · Clinical Chemistry · 1999 · 95 citations · Full text

Pharmacy, Pharmaceutical Analysis, Toxicology +15

Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-<i>d</i>]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family

Jeff B. Smaill, Andrea J. Gonzales, Julie A. Spicer et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring

Mark L. Boys, Feng Bian, James B. Kramer et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +6